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ABSTRACT 29 
Characterizing the mycobacterial transporters involved in the uptake and/or catabolism of host-30 
derived nutrients required by mycobacteria may identify novel drug targets against 31 
tuberculosis. Here, we identify and characterize a member of the amino acid-polyamine- 32 
organocation superfamily, a potential γ-aminobutyric acid transport protein, GabP, from 33 
Mycobacterium smegmatis. The protein was expressed to a level allowing its purification to 34 
homogeneity and Size Exclusion Chromatography-Multi Angle Laser Light Scattering analysis 35 
of the purified protein showed that it was dimeric. We showed that GabP transported γ-36 
aminobutyric acid in vitro and when over-expressed in E. coli. Additionally, transport was 37 
greatly reduced in the presence of β-alanine, suggesting that it could be either substrate or 38 
inhibitor of GabP. Using GabP reconstituted into proteoliposomes, we demonstrated that γ-39 
aminobutyric acid uptake is driven by the sodium gradient and is stimulated by membrane 40 
potential. Molecular docking showed that γ-aminobutyric acid binds MsGabP, another 41 
Mycobacterium smegmatis putative GabP and the Mycobacterium tuberculosis homologue in 42 
the same manner. This study represents the first expression, purification and characterization 43 
of an active γ-aminobutyric acid transport protein from mycobacteria. 44 
  45 
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IMPORTANCE 46 
The spread of multidrug resistant tuberculosis increases its global health impact in humans. As 47 
there is transmission both to and from animals, the spread of the disease also increases its 48 
effects in a broad range of animal species. Identifying new mycobacterial transporters will 49 
enhance our understanding of mycobacterial physiology and furthermore provides new drug 50 
targets. Our target protein is the gene product of msmeg_6196, annotated as GABA permease, 51 
from Mycobacterium smegmatis strain MC2 155. Our current study demonstrates that it is a 52 
sodium-dependent GABA transporter that may also transport β-alanine. As GABA may well 53 
be an essential nutrient for mycobacterial metabolism inside the host, this could be an attractive 54 
target for the development of new drugs against tuberculosis.  55 
  56 
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INTRODUCTION 57 
Tuberculosis (TB), one of the oldest and deadliest human diseases, is caused by Mycobacterium 58 
tuberculosis (Mtb). Mtb is a leading infectious killer, claiming the lives of about 1.2 million 59 
people annually (1). It is a re-emerging pathogen, due to the development of multiple-drug 60 
resistant (MDR) and extensively-drug resistant (XDR) strains (2). In addition, animal 61 
tuberculosis is a globally distributed zoonotic chronic disease, posing a significant impact on 62 
the costs in global agricultural losses (3). Since transmission between humans and animals has 63 
been demonstrated in both directions, TB has been described as a One Health issue, having 64 
similar consequences for humans and animals (4), and causing huge socioeconomic impact 65 
both in terms of human lives and resources. 66 
The unique cell wall composition of Mtb is believed to be the major determinant of its 67 
resistance to a large range of antibiotics (5), leading to a continuing need to discover new ones. 68 
A new approach to developing therapeutics against TB is through comprehensive discovery 69 
and characterization of metabolic pathways, their impact on key features of Mtb pathogenesis 70 
(6) and their contribution to drug resistance. Because Mtb has a reduced genome (7), it has 71 
neither extended de novo synthesis pathways nor duplicated transporters – the essential 72 
transmembrane proteins that mediate the nutrient uptake and metabolite efflux (8), meaning 73 
that there are many essential metabolites. The transporters, required for the uptake of essential 74 
nutrients, enable mycobacteria to persist in the harsh intracellular host environments by 75 
scavenging nutrients. They thus represent potential new drug targets. Characterizing unique 76 
mycobacterial transporters provides another route to discover novel therapeutics to treat TB 77 
(9). 78 
Despite considerable progress in the development of genetic methods for mycobacteria the 79 
function of many transporters is still unknown. Nonetheless, AnsP1, an aspartate importer, was 80 
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identified by targeted mass-spectrometry based metabolomics. This method targets a pre-81 
defined group of compounds and aims to determine which one is transported. A mixture of 82 
biomolecules is introduced into the mass spectrometer either directly or following a separation 83 
procedure. In particular, liquid chromatography-mass spectrometry-based targeted 84 
metabolomics achieves high level sensitivity and accuracy (10). AnsP1 was shown to be 85 
involved in nitrogen metabolism and essential for mycobacterial infection and survival (11-86 
13). This provides evidence that Mtb relies on amino acid uptake and degradation pathways to 87 
thrive inside the host and confirms a strong link between nutrition and pathogenicity in Mtb. 88 
To identify the substrates of other orphan transporters from mycobacteria, we adopted a similar 89 
approach for five homologous genes of AnsP1 from three different mycobacterial species. 90 
From this initial screen, the annotated GABA permease from Mycobacterium smegmatis MC2 91 
155, (MsGabP hereafter), proved promising for further studies. M. smegmatis is widely used 92 
as a convenient model system to study Mtb biology, cell structure and persistence under 93 
conditions of nutrient starvation (14) because it has a faster growth rate and lower biosafety 94 
level than M. tuberculosis. Based on its sequence, this putative permease belongs to the group 95 
of amino acid-polyamine-organocation (APC) superfamily of transport proteins (15), which is 96 
widely found in all living organisms. To date, no in vivo or in vitro information is available for 97 
Mycobacterium smegmatis GabP despite it being annotated as a probable GABA permease 98 
based on its sequence identity to E. coli GabP (16). The hydropathic profile produced by 99 
TMHMM2 predicted that MsGabP has twelve transmembrane-spanning helices (17). 100 
Homology modelling of the protein shows that it adopts an arrangement known as the LeuT 101 
fold (18) (Fig. S1). 102 
In eukaryotes, besides its primary function as an inhibitory neurotransmitter (19), GABA may 103 
have a role in the modulation of immune responses (20) but it is unclear whether and how 104 
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GABAergic signalling regulates antimicrobial host defences during infections. GABA does, 105 
however, act as a specific cytotoxicity and virulence regulator of Pseudomonas aeruginosa 106 
(21). Bacteria, such as Bacillus subtilis (22), P. syringae (23) and isolated E. coli mutants (24), 107 
can use GABA as a sole nitrogen source. Furthermore, GABA is known to be important for 108 
acid resistance in bacteria including E. coli (25) and Lactobacillus (26). In the Mtb vaccine 109 
strain M. bovis BCG, uptake of GABA was not induced by carbon and nitrogen starvation (27). 110 
Beyond this, the mechanism and implications of GABA transport and metabolism have not 111 
been extensively examined in mycobacteria.  112 
We report here the successful expression of M. smegmatis MC2155 GabP in E. coli. SEC-113 
MALLS analysis of the purified protein showed that it is a homodimer. In vitro and in live 114 
recombinant bacteria functional experiments allowed us to confirm predictions that it is a 115 
GABA transporter. We also showed that substrate uptake by MsGabP is sodium-driven and 116 
depends on the membrane potential. 117 
  118 
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RESULTS 119 
MsGabP is expressed in E. coli. 120 
MsGabP was inducibly expressed in E. coli under the control of the IPTG inducible promotor 121 
Tac. The expression level was tested by western blot in five strains and three different media 122 
(Fig. 1). In strains C41 (DE3) ΔacrB pRARE2 or C43 (DE3) ΔacrB pRARE2, we observed 123 
only a very low level of expression in SB medium (Fig. 1, panel 1S and 2S). Conversely, in the 124 
other strains, the expression level was higher when the cells were cultures in SB (Fig. 1, panel 125 
3S, 4S and 5S) than in LB medium (Fig. 1, panel 3L, 4L and 5L). Densitometry measurements 126 
(Fig. S2) confirmed that MsGabP expresses best with BL21 Gold (DE3) pRARE2 as the strain 127 
in SB auto-induction medium. The expression level with C41 (DE3) ΔacrB and SB auto-128 
induction medium was about 65% of that level (Fig. 1, panel 3S and 5S). We nonetheless chose 129 
this last condition for further optimization, since AcrB, which is a known contaminant of 130 
purified membrane protein from E. coli, is deleted in this last strain. Following further 131 
optimization (data not shown), we determined that the optimal expression conditions in C41 132 
(DE3) ΔacrB strain was SB auto-induction medium for 24 hours at 37 °C. 133 
The protein eluted at approximately 36 kDa on sodium dodecyl sulfate-polyacrylamide gel 134 
electrophoresis (SDS-PAGE), though the predicted molecular mass is 50.7 kDa. (see 135 
Purification of MsGabP below). 136 
 137 
Targeted Metabolomics suggest GABA and serine as potential substrates of MsGabP. 138 
We used targeted metabolomics to identify potential substrates (see Materials and Methods). 139 
We expressed MsGabP in E. coli using the pL33 plasmid and tested for uptake of following 140 
amino acids: GABA, arginine, lysine, aspartate, asparagine, glutamine, glutamate and serine. 141 
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The rationale was as follows: GABA because MsGabP is annotated as a GABA permease; 142 
arginine and lysine because it belongs to the APC superfamily of transporters; aspartate, 143 
asparagine, glutamine, glutamate because it has about 35-36% identity to Mtb AnsP1 and 144 
AnsP2, which transport asparagine; and serine, which is polar but not charged, as a negative 145 
control. We observed a two-fold differential in internal GABA concentration with 1 mM 146 
GABA in energized E. coli cells containing MsGabP (Fig. 2A). Similarly, with 5 mM serine, 147 
there was about a seven-fold differential (Fig. 2B), suggesting these two amino acids could 148 
represent potential substrates. No transport of the other tested amino acids was detected. For 149 
instance, neither 1 mM nor 5 mM arginine and aspartate increased the concentration of the 150 
respective amino acid in the MsGabP cells compared to control cells (Fig. S3).  151 
 152 
MsGabP transports radiolabelled GABA into cells.  153 
To confirm the uptake of potential amino acids by MsGabP, we next performed radiolabelled 154 
transport assays on intact cells. Consistent with the metabolomics study results, E. coli cells 155 
overexpressing MsGabP are able to uptake radioactive GABA (Fig. 3). As control, cells (empty 156 
plasmid) only showed a negligible uptake of radioactive GABA. This clearly shows that the 157 
uptake of GABA was indeed due to the overexpressed MsGabP and not linked to E. coli 158 
endogenous GABA transporters. In contrast, radioactive serine was not transported by 159 
MsGabP, suggesting that serine is not a true substrate of the transporter (data not shown). 160 
Interestingly, β-alanine, a structural analogue of GABA, competed with the uptake of 161 
[3H]GABA into energized E. coli whole cells (Fig. 3), suggesting that it might bind as a 162 
competitive inhibitor of GABA. GABA uptake was also significantly decreased when a 163 
protonophore, 50 μM of carbonylcyanide m-chlorophenylhydrazone (CCCP), was added with 164 
9 
 
GABA to the assay (Fig. 3), indicating that the transport depends on the proton gradient and/or 165 
on the membrane potential. 166 
 167 
Purification of MsGabP. 168 
We next wanted to study the transport of amino acids with purified and reconstituted MsGabP 169 
and we therefore tested a range of detergents for solubilization efficiency. n-Decyl-β-D-170 
Maltopyranoside (DM), n-Undecyl-β-D-Maltopyranoside (UDM), n-Undecyl-β-D-171 
Thiomaltopyranoside (UDTM) and n-Dodecyl-β-D-Maltoside (DDM) at 1% all extracted 172 
MsGabP from the membranes with similar efficiencies (~80%), as quantified after western blot 173 
analysis (Fig. 4A). Since DDM has a lower critical micellar concentration (CMC) than DM, 174 
we decided to proceed with DDM for solubilizing the protein in large scale purification. 175 
Preliminary purifications in DDM showed that the purified protein was unstable and contained 176 
contaminants (not shown). We therefore used the HRV-3C-His-tag to perform on-column 177 
detergent exchange followed by on-column cleavage to elute MsGabP to identify detergents 178 
that stabilized the purified protein. To identify the best one, small scale purifications were 179 
conducted with 12 different detergents (Table 1). The stability was then assessed by microscale 180 
fluorescent thermal stability assay (28). The protein unfolded cooperatively in DDM, Decyl 181 
Maltose Neopentyl Glycol (DMNPG), UDTM, n-Dodecyl-β-D-Thiomaltopyranoside (DDTM) 182 
and n-Tridecyl-β-D-Maltopyranoside (13M) (Fig. 4B) under the buffer conditions tested. This 183 
suggests that MsGabP is correctly folded in all of these detergents. However, it was most stable 184 
in 13M or DMNPG (Tm of 51.4 ± 0.1°C and 51.2 ± 0.2°C) (Fig. 4B), which is about 4°C higher 185 
than in DDM (Fig. 4B). As the final yield from DMNPG was higher than from 13M (Table 1), 186 
we used DMNGP for further experiments. Yields of ~0.7 mg protein per litre of bacterial 187 
culture were typically achieved. 188 
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Fractions collected during the protein elution from the resin showed the presence of two bands, 189 
migrating at ~36 kDa and ~70kDa respectively (Fig. 5A). Peptides generated by tripsin 190 
digestion of the protein bands were analyzed using mass spectrometry. The acquired spectra 191 
were analyzed in PEAKS software, which allowed us to identify MsGabP with 12 unique 192 
peptides and a total sequence coverage of 14% in the lower band at 36 kDa and 2 unique 193 
peptides and a total sequence coverage of 3% in the upper band at 70 kDa (Fig. S4). In the 194 
lower 36 kDa band we are able to detect peptides from the N-terminus, the middle of the 195 
MsGabP and the C-terminus, consistent with a full-length protein, as is shown by the fact that 196 
it is active in GABA transport (see below). The 70 kDa band is either a protein homodimer or 197 
a partially folded monomer, but most likely the latter (29). 198 
 199 
Purified MsGabP is a dimer.  200 
The absolute molecular weight of the purified protein-detergent complex was determined by 201 
SEC-MALLS (Fig. 5B). The protein eluted as a single, symmetrical peak at ~0.4 column 202 
volume, demonstrating its homogeneity and mono-dispersion (Fig. 5B). Using the three-203 
detector method (30), the molecular  mass of MsGabP in the main peak was found to be 204 
79.2 ± 5.7% kDa, indicating the protein is dimeric in the protein-detergent complex. 205 
 206 
MsGabP-driven GABA transport depends on both Na+ and membrane potential. 207 
To study MsGabP function free from E. coli metabolism and interference by its endogenous 208 
amino-acid transporters, we reconstituted purified MsGabP into liposomes. The migration 209 
(‘flotation’) of proteoliposomes on a discontinuous sucrose gradient demonstrated successful 210 
reconstitution of the protein into liposomes with an efficiency of ~90% (Fig. S5), as a majority 211 
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of the proteoliposomes float into the 5% and 2.5% fractions of the gradient. We were therefore 212 
able to use these to study the transport mechanism of MsGabP. 213 
Radioactive transport assays showed there was a significantly higher accumulation of 3H-214 
GABA in proteoliposomes containing MsGabP as compared to protein-free liposomes 215 
(MsGabP vs control), when proteoliposomes loaded with K+ were diluted into a buffer with 216 
Na+ (Fig. 6A). We were unable to measure any transport of 3H-GABA into proteoliposomes 217 
using pH gradients alone (Fig. 6B/CCCP). In contrast, the addition of the potassium-conducting 218 
ionophore valinomycin (31) in the transport buffer (with Na+ present) established a negative 219 
inside potential that led to increased GABA transport compared to the uptake level in the 220 
absence of valinomycin (Fig. 6B/Val). When the membrane potential generated by 221 
valinomycin is abolished by the addition of CCCP, the uptake activity was negligible (Fig. 222 
6B/Val and CCCP). Importantly, when choline chloride was used in place of NaCl in the 223 
presence of valinomycin, GABA uptake was abolished completely indicating that Na+ was 224 
essential for transport (Fig. 6B/Val, compare Na+ out vs ChoCl out). To confirm that the pH 225 
gradient does not contribute to GABA transport, we trapped a membrane impermeant 226 
fluorescent pH indicator, pyranine, in the proteoliposomes. No change in pH was recorded in 227 
upon the addition of GABA in MsGabP containing proteoliposomes. This confirms that protons 228 
are not involved in GABA uptake (Fig. 6C).  229 
 230 
Phylogenetic analysis shows that E. coli GabP and B. subtilis GabP are closely related to 231 
MsGabP and MtbGabP 232 
A tblastn search against mycobacterial genomes using E. coli GabP and an E-value of e-100, 233 
retrieved sequences across the whole span of Mycobacteria, including sequences from the 234 
pathogenic species M. tuberculosis, M. ulcerans, M. avium and M. abscessus. The primary 235 
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sequences of MsGabP and MtbGabP (Rv0522) are 47% identical (56% BLOSUM62 score 236 
similar), while MsGabP and E. coli GabP are 43% identical (62% similar). We also noted that 237 
the gene product of msmeg_5473 (Ms5473 hereafter) shares 49% identity with MtbGabP and 238 
41% identity with MsGabP, suggesting that it is also closely related to MtbGabP. A 239 
phylogenetic tree of bacterial protein sequences related to E. coli, B. subtilis and M. 240 
tuberculosis GabP shows there are two different groups of GabP sequences, each containing 241 
members from Proteobacteria, Bacilli and Actinobacteria. The first group includes the 242 
sequences from E. coli (P25527), Pseudomonas syringae (Q87UE3), Bacillus subtilis GabP 243 
(P46349), Streptomyces coelicolor (Q9L202) and Corynebacterium glutamicum AroP 244 
(Q46065), a protein characterised as an aromatic amino acid transporter. The second group has 245 
a less varied taxonomic distribution and comprises mainly Actinobacteria sequences, including 246 
MsGabP and MtbGabP, but also Bacillales, − and -Proteobacteria (Fig. S6).  247 
 248 
Docking studies suggest that the residues involved in GABA binding are conserved 249 
between MsGabP, MtbGabP and Ms5473.  250 
To identify potential substrate binding sites in the MsGabP, MtbGabP and Ms5473 models (see 251 
Methods and Materials), molecular docking of GABA to the models with Grid-based Ligand 252 
Docking with Energetics (Glide) software (32) was performed. All predicted GABA binding 253 
poses exhibited clusters located in the same area of the protein (Fig. S7), corresponding to the 254 
outward-facing occluded conformation of the transporter as found in L-arginine/agmatine 255 
antiporter AdiC (33). The residues that interact with GABA are strongly conserved and form 256 
conserved interactions with the ligand, suggesting that they are involved in substrate binding, 257 
consistent with GABA binding to all three transporters. The side chain of E119 (in 258 
MsGabP)/E89 (in MtbGabP) appears to hydrogen bond to the -amino group in GABA, while 259 
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this interaction is absent in Ms5473. Instead, it appears to interact with S297, which would be 260 
a weaker interaction (Fig. S7). 261 
  262 
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DISCUSSION 263 
The ability of Mtb to adapt its metabolism to environmental changes, including various stress 264 
conditions, is believed to be critical for its pathogenicity (34). It is known that amino acids 265 
support growth of Mtb in vitro (12). However, we lack knowledge about the regulation of 266 
amino acid transport and metabolism in mycobacteria. The identity of many transporters 267 
involved in this process in Mtb is still unknown. 268 
Here we characterize, for the first time, the putative mycobacterial GABA permease from M. 269 
smegmatis strain MC2 155. MsGabP is closely related to MtbGabP and M. bovis GabP (27) 270 
(47% sequence identity) and to the previously characterized GABA permeases from B. subtilis 271 
(35) and E. coli (24) (48% and 43% sequence identity) respectively. GABA transport is an 272 
important aspect of GABA metabolism and is regulated in concert with GABA catabolism 273 
enzymes in other bacteria. Although nitrogen-limited culture conditions induce GABA 274 
permease expression in E. coli and B. subtilis (36, 37) the regulatory mechanisms are different. 275 
As in B. subtilis (22) GabP and metabolic enzymes in mycobacteria are not physically 276 
clustered, suggesting it might exhibit functional characteristics distinct from the E. coli GabP, 277 
where there is coordinated regulation of the gab gene cluster (24, 38). 278 
MsGabP was successfully expressed in C41 (DE3) ΔacrB cells grown in SB auto-induction 279 
(Fig. 1) medium with a yield of 0.7 mg/L culture, extending the success of using pTTQ18 based 280 
plasmids for the expression of a range of membrane transporters (39). This provided us with a 281 
platform for our metabolomics and other studies. We initially used in vivo (using a heterologous 282 
host) targeted metabolomics to identify potential MsGabP substrates. Our metabolomics 283 
analysis suggested that GABA and serine might both be substrates of MsGabP (Fig. 2), but not 284 
asparagine, aspartate or lysine (Fig. S3).  285 
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Further functional characterization, using radiolabelled uptake assays with energized E. coli 286 
whole cells (Fig. 3), clearly demonstrated MsGabP mediated GABA uptake, and therefore 287 
confirmed that MsGabP is a GABA transporter. Uptake rate was in the range of ~0.05 µmol/mg 288 
cells, but it was essentially abolished, to ~0.01 µmol/mg cells in the presence of 50 μM CCCP 289 
(Fig. 3). Similarly, CCCP inhibited GABA uptake by non-homologus GabP in C. glutamicum 290 
(40). We have shown however that GABA uptake does not involve protons, therefore 291 
suggesting that transport is dependent on membrane potential rather than proton gradient. 292 
GABA uptake by MsGabP was also sensitive (~70%) to competition with β-alanine (Fig. 3), 293 
as previously observed for both eukaryotic (41) and prokaryotic (42) GABA transporters. 294 
Unfortunately, we could not measure uptake of β-alanine as we could not obtain it 295 
radiolabelled. Therefore, we could not determine if β-alanine is only a competitor or if it is a 296 
true MsGabP substrate. Interestingly, B. subtilis GabP transports β-alanine 500 times more 297 
efficiently than the E. coli transporter, reflecting the differences in binding domains of various 298 
GABA permeases (42).   299 
We next aimed to purify MsGabP, to perform more reliable transport measurements in 300 
proteoliposomes. We screened for conditions that maintain protein stability and 301 
monodispersity prior to reconstitution. Membrane protein purification strategy success depends 302 
on the type of detergent used for solubilization and the subsequent purification steps. The on-303 
column detergent exchange method adopted here represents a fast, versatile and economical 304 
approach to screen a series of detergents (43–44). Solubilization trials (Fig. 4A) of membrane 305 
preparation from cells with amplified expression of MsGabP using 12 different detergents at a 306 
concentration of 1% identified DDM as the best detergent. Though DDM can extract MsGabP 307 
efficiently from the membrane, DMNPG was preferred for its ability to stabilize the protein 308 
and was therefore used in downstream experiments.  309 
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Purified MsGabP was found to be dimeric in DMNPG (Fig. 5). This is not uncommon amongst 310 
this family: mouse GAT1 appears to form both dimers and high-order oligomers as shown by 311 
in vivo FRET experiments (45). Li and colleagues (46) showed that Fos-Choline 12 purified 312 
GABA transporter from E. coli is monomeric in solution. The difference in oligomerisation 313 
state is probably due to the FC-12, which is zwitterionic and much harsher than DMNPG, and 314 
so presumably denatures the protein (47, 48).  315 
We reconstituted MsGabP into proteoliposomes with 90% efficiency (Fig. S5). The presence 316 
of proteoliposomes in the upper fractions upon flotation on discontinuous sucrose gradient 317 
reflects successful protein incorporation (49). Like other secondary active transporters, 318 
substrate uptake by GABA transporter is driven by electrochemical ion gradients (50) and the 319 
co-transported ions vary among different organisms. Direct measurement of GABA transport 320 
with proteoliposomes showed that GABA uptake was tightly coupled with sodium cations 321 
(Na+) (Fig. 6), as previously seen in a non-homologus C. glutamicum transporter (40).  322 
A phylogenetic analysis (Fig. S6) of closely related sequences to GabP shows that this group 323 
of transporters is present across different classes of bacteria and includes the experimentally 324 
characterized GABA transporters of E. coli, B. subtilis and P. syringae, although at least one 325 
member, Ncgl1062 from C. glutamicum, has been shown to be an aromatic amino acid 326 
transporter. All Mycobacterium species analysed have one GabP sequence for which the 327 
phylogenetic distribution follows the evolutionary history of the genus, suggesting that it was 328 
present in the last common ancestor of all mycobacteria. It is reasonable to assume that in this 329 
orthologous cluster, the ability to transport GABA is preserved and that the annotation of 330 
Rv0522 as a GABA permease is appropriate. Some mycobacteria have a second GabP 331 
sequence that was probably acquired by lateral gene transfer, from within the same group of 332 
transporters: this includes M. smegmatis. Here we have shown that this second member is also 333 
a GABA transporter. Finally, structural analysis of the docked complexes revealed a similar 334 
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binding pocket for GABA in all three homologues, with GABA being recognized by conserved 335 
amino acids residues (Fig. S7). The poses for MsGabP and MtbGabP are more similar than that 336 
of Ms5473, supporting our argument that both MsGabP and MtbGabP are GABA transporters. 337 
We can only speculate, but MsGabP and Ms5473 may differ in when they are expressed, and/or 338 
in their relative affinities for GABA, as is the case in S. aureus, which has two proline 339 
transporters (51). 340 
GABA may be an important metabolite required for mycobacterial pathogenesis, raising the 341 
therapeutic potential of inhibitors towards GABA permease. We hope these studies will lead 342 
to structural and further biochemical exploration of this novel mycobacterial transporter, 343 
resulting in the discovery of new potent drugs against TB.  344 
  345 
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MATERIALS AND METHODS. 346 
General. The primers used for PCR were from Sigma-Aldrich (St. Louis, MO, USA), enzymes 347 
for cloning from New England Biolabs (Ipswich, MA, USA), the reagents for the bicinchoninic 348 
acid (BCA) assay from Thermo Fisher Scientific (Waltham, MA, USA), His tag horseradish 349 
peroxidase-conjugated antibody from Bio-Techne (Minneapolis, MN, USA), detergents from 350 
Anatrace (Maumee, OH, USA), and radiolabelled γ-[2,3-3H(N)]-aminobutyric acid 351 
([3H]GABA) from Perkin Elmer (Waltham, MA, USA). All other chemicals were from Sigma-352 
Aldrich (St. Louis, MO, USA) and were of analytical grade or better. The Mycobacterium 353 
smegmatis MC2 155 strain was purchased from ATCC (Manassas, VA, USA), C41 (DE3) 354 
ΔacrB from Lucigen Corporation (Middleton, WI, USA), BL21 Gold (DE3) from Stratagene 355 
(La Jolla, CA, USA), BL21 Star (DE3) from Thermo Fisher Scientific (Waltham, MA, USA) 356 
and plasmid pRARE2 from Novagen (the Merck Group, Darmstadt, DE). All media, buffers 357 
and other solutions were prepared using deionized water. All media were sterilized by 358 
autoclaving or for thermally sensitive solutions by passage through 0.2 µM filters from 359 
Millipore. 360 
Cloning. An expression vector pL33 for the production of MsGabP was constructed by using 361 
the vector pTTQ18 (52). pL33 encodes a C-terminal His tag preceded by an HRV-3C protease 362 
cleavage site (53). The gene msmeg_6196 encoding GabP was amplified with M. smegmatis 363 
MC2 155 genomic DNA as template by PCR using the upstream primer with NheI site, 5’-364 
GCTAGCCTCGAATCGAGATCCGATCTG-3’, and downstream primer with SbfI site 5’-365 
CCTGCAGGCTCATCGGTTCTCGCAGC-3’. The amplified fragment was digested with 366 
NheI and SbfI and inserted between the corresponding sites of plasmid pL33 to construct the 367 
expression plasmid pL33-MsGabP. 368 
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Cell growth and membrane preparation. Expression tests for MsGabP were performed using 369 
E. coli strains: C41 (DE3) ΔacrB, C41 (DE3) ΔacrB pRARE2, C43 (DE3) ΔacrB pRARE2, 370 
BL21 Gold (DE3) pRARE2 and BL21 Star (DE3) pRARE2 and three different types of media 371 
for cell growth (Lysogeny broth (LB), Superbroth (SB) and M9 auto-induction media) in 24 372 
deep-well plates (Whatman plc, GE Healthcare, IL, USA) at 37°C for 24 h with shaking at 373 
1,300 rpm (54). Isopropyl β-D-1-thiogalactopyranoside (IPTG) induction and auto-induction 374 
were compared to determine which condition produced more of the target protein. 10 μg of 375 
lysed cells (54) was loaded onto SDS-PAGE and protein expression determined by western 376 
blot using His tag horseradish peroxidase-conjugated antibody. Large-scale expression of 377 
MsGabP was performed in a 30 L fermentor (Infors HT). The cells were grown in SB auto-378 
induction medium at 37°C for 24 h and harvested by centrifugation (6000 x g, 20 min, 4°C). 379 
The cells were resuspended in 1 × PBS buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM 380 
NaCl, 4 mM KCl, pH 7.4) with a ratio of 6 ml buffer/g cells. Membranes were prepared 381 
following the protocol in (54), resuspended with 1 × PBS buffer and total protein concentration 382 
in the membrane was measured by BCA assay (55). 383 
Solubilization and purification of MsGabP. The solubilization test was carried out at 4°C 384 
with 12 different detergents (Table 1). The membrane fraction of E. coli/MsGabP adjusted to 385 
2 mg/ml was incubated in 20 mM Tris (pH 8.0), 150 mM NaCl, 10% (v/v) glycerol and 1% 386 
(w/v) of the tested detergent at 4°C for 1 h. Samples before and after centrifugation at 387 
100,000  × g for 1 h were analyzed by western blot. Purification was started with 100 mg of 388 
total membrane protein that was homogenized and solubilized for 1 h at 4°C in solubilization 389 
buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 4 mM KCl, 287 mM NaCl, 7.5 mM imidazole, 390 
10% (v/v) glycerol, pH 7.4) with 1% (w/v) DDM at a protein concentration of 5 mg/ml, 391 
followed by removal of insoluble material by centrifugation at 100,000 × g for 1 h. The 392 
supernatant was incubated with 1 ml HisPurTM cobalt resin (50% slurry) (Thermo Fisher 393 
20 
 
Scientific, Waltham, MA, USA), pre-equilibrated with wash buffer 1 (same composition as the 394 
solubilization buffer) containing 0.05% (w/v) DDM at 4°C, for 2 h with gentle mixing. 395 
Immobilized-metal affinity chromatography (IMAC) was performed by mixing the supernatant 396 
with the equilibrated resin for 2 h with gentle mixing. The resin was then packed into the 397 
Econo-Pac® disposable gravity-flow chromatography column (Bio-Rad, Hercules, CA, USA). 398 
Unbound material was collected followed by washing of the column with ~10 x column 399 
volumes of wash buffer 1 and 2 (differing from wash buffer 1 only by the imidazole 400 
concentration, which was 10 mM). 401 
On-column detergent exchange. Detergent was exchanged on-column from DDM into 402 
CYMAL 6, β-OG, OGNPG, DMNPG, LMNPG, DM, UDM, UDTM, DDTM, 13M and 14M 403 
by replacing DDM in the wash buffer 2 with 3 × CMC of each detergent. The resin then was 404 
washed with a wash buffer 3 (20 mM HEPES, (pH 7.0), 100 mM NaCl, 5% (v/v) glycerol, 3 × 405 
CMC of detergent) for 8 x column volume to remove imidazole. HRV-3C protease was then 406 
added at a molar ratio of 1:1 to the target protein to the resin with a minimal volume of wash 407 
buffer 3 and incubated at 4°C overnight to cleave the His tag. The following day, the protein 408 
was eluted from the column using ~7 ml of a wash buffer 3 and then concentrated to a volume 409 
of ~100 µl by centrifugation using a concentrator with a MW cut off of 50 kDa (Vivaspin 2, 410 
Sartorius). 411 
Microscale fluorescent thermal stability assay. The stability of the protein purified in 412 
different detergents was checked by microscale fluorescent thermal stability assay as described 413 
in (28) with the following modifications. The buffer used for dilution of the dye N-[4-(7-414 
diethylamino-4-methyl-3-coumarinyl)phenyl] maleimide (CPM) was the same as the buffer 415 
that the protein sample was eluted with. After briefly mixing the dye and the protein sample, 416 
the mixture was equilibrated at room temperature for 10 min while protecting it from light, and 417 
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then placed into the Stratagene Mx3005P Real Time PCR machine (Agilent Technologies, 418 
Santa Clara, CA, USA). The ramp rate was 4°C/min and the starting and ending temperatures 419 
were 25°C and 90°C. Data were processed with GraphPad Prism program (GraphPadPrism for 420 
Mac, GraphPad Software, San Diego, CA, USA [http://www.graphpad.com/scientific-421 
software/prism/]). 422 
Size Exclusion Chromatography-Multi Angle Laser Light Scattering. The molecular mass 423 
and the oligomerization state of the purified MsGabP was determined via size exclusion 424 
chromatography coupled to light scattering, absorbance and differential refractive index 425 
detectors method. The refractive index and light scattering detectors were from Wyatt 426 
Technology (Goleta, CA, USA) and the UV detector and chromatography pumps from 427 
Shimadzu Corporation (Kyoto, Japan). The Superose 6 column (WTC-MP030S5 (Wyatt 428 
Technology, Goleta, CA, USA)) was equilibrated with 20 mM HEPES (pH 7.0), 100 Mm 429 
NaCl, 5% (v/v) glycerol, 0.0102% (w/v) DMNPG overnight. 30 µl of MsGabP (3 mg/ml) was 430 
injected and the sample eluted from the column was analyzed by three detectors (30). Data 431 
obtained were analyzed using ASTRA software package, version 6.1 (Wyatt Technology, 432 
Goleta, CA, USA). The program calculated MW,protein, MW,detergent and MW,total throughout the 433 
peak and also provides information on the monodispersity of the peak (56). 434 
Targeted metabolomics study. E. coli strain C41 (DE3) ΔacrB harbouring pL33 or pL33-435 
MsGabP were cultured in 50 ml LB medium at 37°C for 8 h in 250 ml shaker flasks. 108 cells 436 
were transferred onto mixed cellulose filters (pore size: 0.22 μm, Merck Millipore, Billerica, 437 
MA, USA) by vacuum filtration and then incubated overnight at 30°C in agar plates (1.5% 438 
(w/v) containing minimal medium (50 mM Na2HPO4, 50 mM KH2PO4, 25 mM (NH4)2SO4, 439 
2  mM MgSO4, trace metals, vitamins, 0.5% glucose) supplemented with ampicillin (100 μg 440 
ml− 1). The cells were adapted for 1 h at 37°C. Filters with the cells were transferred onto 441 
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minimal medium agar (1.5% (w/v)) plates supplemented with the specific amino acid tested 442 
(1 mM or 5 mM), 0.5 mM IPTG and ampicillin (100 μg ml− 1), and incubated for 0.5 h at 37°C. 443 
The cells were harvested and transferred to 1 ml acetonitrile/methanol/water (2:2:1 v/v/v) 444 
solution. The cells were then disrupted using a bead beater and polar metabolites were 445 
extracted. After centrifugation, supernatants were collected and filtered with 0.22 μm spin-X 446 
column filters (Costar, Corning Inc., NY, USA). Extracts were stored at -80°C before analysis. 447 
The amino acids tested were arginine, aspartate, asparagine, GABA, glutamate, glutamine, 448 
lysine, and serine. The liquid chromatography-mass spectrometry was performed as described 449 
(57). Aqueous normal phase liquid chromatography was performed using an Agilent 1200LC 450 
system with a flow rate of 0.4 ml/min. Elution of polar compounds was performed using a 451 
gradient of solvents A (Milli-Q water and 0.2% acetic acid) and B (acetonitrile and 0.2% acetic 452 
acid). Accurate mass spectrometry was performed using an Agilent Accurate Mass 6230 TOF 453 
apparatus equipped with Multi-mode Ion source. Data were analyzed using Qualitative 454 
Analysis B.07.00 software and the metabolites were identified comparing the accurate m/z 455 
(error less than 10 ppm) and the retention time with the accurate m/z and the retention time of 456 
standard solutions for the specific metabolite. The ions counts were recorded and normalized 457 
to the residual protein content (detected by BCA assay) present in each extract. 458 
Whole-cell radiolabeled assay. C41 (DE3) ΔacrB E. coli was grown in M9 minimal medium 459 
supplemented with glycerol (20 mM) and carbenicillin (100 μg ml− 1) in volumes of 50 ml at 460 
37°C in 250 ml baffled conical flasks with aeration at 200  rpm to an OD680 of ∼0.4–0.6. The 461 
cells were then either un-induced or induced with IPTG (0.5 mM) for further 1 h. Harvested 462 
cells (by centrifugation at 2500 x g for 10  min) were washed three times with 40  ml of buffer 463 
(5 mM MES, pH 6.6, 100 mM NaCl and 50 mM KCl) and then resuspended to a cell density 464 
of A680 ~2.0. Cell suspension (196 μl) containing 20 mM glycerol was aerated in a bijou bottle 465 
held in a water jacket at 37°C for 3 min, and then [3H]GABA (50 μM) with a specific activity 466 
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of 10 μCi/ml was added with brief mixing. Exactly 10 min after adding the [3H]GABA, 80 μl 467 
aliquots were transferred to cellulose nitrate filters (0.45 μm pore size), pre-soaked in transport 468 
buffer, on a vacuum manifold and washed with transport buffer (6  ml). The filters were 469 
transferred to scintillation vials with 10 ml Emulsifier-Safe liquid scintillation fluid (Perkin 470 
Elmer) and incubated overnight. The level of [3H] radioactivity was measured by liquid 471 
scintillation counting (Packard Tri-Carb 2100TR instrument, Perkin Elmer, Waltham, MA, 472 
USA). The measured value of disintegrations per minute was converted into μmol/mg cells. 473 
Background counts were measured by washing filters under vacuum in the absence of cells or 474 
radiolabeled substrate. Standard counts were measured by transferring 1, 2.5, 5 and 10 μl 475 
radiolabeled substrate stock solution directly to a washed filter in the vial.  476 
To test the effect of CCCP on transport, it was added at a final concentration of 50 µM. To test 477 
the effect on [3H]GABA uptake, unlabelled β-alanine (final concentration 5 mM) was added to 478 
the cells prior to energizing the proteoliposomes. [3H]GABA was added 5 min after and 80 μl 479 
aliquot was taken to measure the radioactivity. 480 
Protein reconstitution and liposome flotation assay. The E. coli lipid extract (Avanti Polar 481 
Lipids, Inc.) dissolved in chloroform was dried under nitrogen and the lipid film was 482 
resuspended by vortexing to 10 mg/ml with reconstitution buffer (25 mM HEPES (pH 6.8), 483 
including 200 mM KCl and 1 mM DTT). The dissolved lipid was then passed eleven times 484 
through 0.4 μm and then 0.2 μm pore size filters (polycarbonate Nucleopore Track Etch 485 
membrane filters) placed inside the barrel of the extruder. To destabilize the liposomes and 486 
allow the insertion of the membrane protein, 1.1% β-octyl glucoside (OG) was added to 1 ml 487 
of liposomes. The purified protein was added at 500:1 lipid to protein ratio and incubated at 488 
4°C for 1 hour. This was then diluted to 15 ml with a reconstitution buffer and centrifuged at 489 
100,000 x g for 1 h at 4°C. Liposome pellets were resuspended in 1 ml of the reconstitution 490 
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buffer. Proteoliposomes were analyzed using a flotation assay in sucrose gradient made of 491 
layers containing 60%, 30%, 10%, 5% and 2.5% (mass/vol.) sucrose. 250 μl of 492 
proteoliposomes were added to 250 μl of 60% sucrose (in 1 x HEPES buffer, pH 6.8). This 493 
fraction was overlaid with 0.5 ml of 30% sucrose, 20%, 10%, 5% and finally 0.4 ml of 2.5% 494 
sucrose. After centrifugation at 259,000 x g for 16 h, the fractions were collected from the 495 
gradient, and analyzed for protein by SDS-PAGE.  496 
Fluorimetric transport assay. The proteoliposomes (5 μL) loaded with 25 mM HEPES 497 
(pH 6.8) 200 mM KCl and 1mM pyranine dye were diluted in a buffer (1 mL) containing 498 
25 mM HEPES (pH 6.8), 200 mM NaCl and equilibrated in a stirred cuvette in the Photon 499 
Technology International QM-1 spectrophotometer (PTI, U.K.) for 3 min. Fluorescence was 500 
monitored using 400 and 450 nm excitation and 509 nm emission. To induce membrane 501 
potential, valinomycin was added (5 nM) at ~60 sec, followed by the addition of 30 mM GABA 502 
at ~160 sec and 0.03 mM CCCP at ~200 sec. The internal pH change was monitored as a 503 
change in the ratio of 450:400 nm pyranine fluorescence (58). 504 
Radiolabeled assay with proteoliposomes. GABA transport was initiated by diluting 6.6 μl 505 
of proteoliposomes loaded with 25 mM HEPES (pH 6.8) 200 mM KCl buffer into 330 μl of 506 
external transport buffer: either 25 mM HEPES (pH 6.8) 200 mM NaCl buffer or 25 mM 507 
HEPES (pH 6.8) 200 mM choline chloride. To determine whether the presence of membrane 508 
potential (ΔΨ) was needed to drive GABA uptake, 5 nM valinomycin and/or 0.03 mM CCCP 509 
were added to the transport buffers. The incubation time was about 60 seconds before starting 510 
the reactions by addition of [3H]GABA (specific activity 10μCi/mL ) at a final concentration 511 
of 50 μM. 10 min after adding the radiolabeled substrate, 80 μl aliquots were transferred to 512 
cellulose nitrate filters (0.45 μm pore size) pre-soaked in transport buffer on a vacuum manifold 513 
and washed immediately with transport buffer (6  ml). The filters were transferred to 514 
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scintillation vials and radioactivity measured as described for the whole cell assay. The 515 
measured value of disintegrations per minute was converted into pmol/mg protein/min. 516 
Phylogenetic analysis. The sequences of Cluster of Orthologous Groups 1113 were 517 
downloaded from EggNOG (59) and clustered using an 80% identity threshold with CD-HIT 518 
(60). An alignment was calculated using Mafft v7.310 FFT-NS-2 (61). Sequences with less 519 
than 400 residues were removed and the alignment was simplified to less than 85% redundancy 520 
with Jalview 2.11 (62). Both termini were truncated to the first and the last column with 100% 521 
occupancy. 522 
Independently, in-house scripts and BLAST+ (63) were used to mine mycobacterial and 523 
selected model bacteria sequences using the sequence of E. coli GABA permease as query and 524 
an expect threshold of e-100. Matches were aligned with MUSCLE (64) and the alignment was 525 
truncated and simplified to less than 95% redundancy as previously explained. Both alignments 526 
were combined using Mafft and checked for redundancy and partial/truncated and very 527 
divergent entries were removed. 528 
The cluster of GabP sequences was then extracted leaving behind those of related the 529 
transporters, e.g. AnsP (P9WQM7), CycA (O33203), YifK (P27837), ProY (P0AAE2), pheP 530 
(P24207), LysP (P25737) and yvbW (O32257).  A final alignment of this cluster was calculated 531 
using Mafft G-INS-I and consisted of 273 sequences. The best-fit evolutionary model for the 532 
alignment was LG+F+R6 as calculated by ModelFinder (65). Maximum likelihood 533 
phylogenetic analysis was done using IQ-TREE v1.6.11 (66) with 100 standard bootstrap 534 
replicates. Phylogenetic trees were visualized with Dendroscope (67). 535 
  536 
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Molecular model of GabPs and molecular docking of GABA. De novo protein modelling 537 
of MsGabP was performed using the Robetta server (68). The protein structures of MtbGabP 538 
and Ms5473 were homology-modelled by Phyre2 (69), using MsGabP protein sequence as 539 
query. The rank matches for both models had 50% identity and 100% confidence, indicating 540 
high probability of modelling success. The graphical user interface Maestro (version 12.4, 541 
Schrodinger LLC, New York, NY, 2020) was used to visualise the three protein models, which 542 
were prepared for molecular modelling using the Protein Preparation Wizard (default settings). 543 
The GABA ligand was drawn in Maestro and a low energy, zwitterionic conformation was 544 
generated using Ligprep (version 12.4 Schrodinger LLC, New York, NY, 2020). A 36 Å 545 
receptor grid encompassing the protein structure was generated centred on a user-defined 546 
residue (MsGabP G223, MtbGabP T193, Ms5473 V210). Molecular docking of the GABA 547 
ligand was performed on each protein model using Glide in SP mode using default settings but 548 
outputting 15 poses (version 12.4, Schrodinger LLC, New York, NY, 2020). The predicted 549 
binding poses of the GABA ligand were ranked by docking score and the list visually inspected 550 
for predicted hydrogen bonding and their associated directionality and length, steric 551 
clashes/unfavourable interactions, and ligand conformations. A GABA binding pose within 552 
each protein model was chosen based on the above criteria.  553 
  554 
27 
 
ACKNOWLEDGEMENTS 555 
The authors are grateful for financial support from the Leeds Beckett University (to A. P. and 556 
V. L. P.), China Scholarship Council (to Y. J.), the Wellcome Trust (ref.019322/7/10/Z), the 557 
Erkko Foundation and the BBSRC (BB/M021610/1) (to A. G.), and the Francis Crick Institute, 558 
which receives its core funding from Cancer Research UK (FC001060), the UK Medical 559 
Research Council (FC001060), and the Wellcome Trust (FC001060) (to L. P. C.), the 560 
Wellcome Trust (104785/B/14/Z) to L. P. C., the National Science Foundation of China 561 
(31870053 to M. B. and 31670498 to Y. W.). AG acknowledges his Royal Society Wolfson 562 
Research Merit Award. The authors thank Dr. Maren Thomsen for performing the SEC-563 
MALLS analysis, Dr. Steven Harbone for providing suggestions on the microscale fluorescent 564 
thermal stability assay, Dr. James Ault for performing the Mass Spectrometry protein analysis, 565 
Lotta Happonen for help with the Mass Spectrometry analysis and Prof. Peter J. F. Henderson 566 
and David Sharples for use of the fermentation facilities at the Faculty of Biological Sciences, 567 
University of Leeds. 568 
  569 
28 
 
REFERENCES 570 
1.  2020. WHO | Global tuberculosis report 2019. 571 
2.  Seung KJ, Keshavjee S, Rich ML. 2015. Multidrug-Resistant Tuberculosis and Extensively 572 
Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med 5:a017863. 573 
3.  Teppawar RN, Chaudhari SP, Moon SL, Shinde SV, Khan WA, Patil AR. 2018. Zoonotic 574 
Tuberculosis: A Concern and Strategies to Combat. Basic Biology and Applications of 575 
Actinobacteria. IntechOpen. 576 
4.  Kaneene JB, Miller R, Steele JH, Thoen CO. 2014. Preventing and controlling zoonotic 577 
tuberculosis: a One Health approach. Vet Ital 50:7–22. 578 
5.  Jarlier V, Nikaido H. 1994. Mycobacterial cell wall: Structure and role in natural resistance 579 
to antibiotics. FEMS Microbiol Lett 123:11–18. 580 
6.  Rhee K. 2013. Minding the gaps: metabolomics mends functional genomics. EMBO Rep 581 
14:949-950. 582 
7.  Stinear TP, Seemann T, Harrison PF, Jenkin GA, Davies JK, Johnson PDR, Abdellah Z, 583 
Arrowsmith C, Chillingworth T, Churcher C, Clarke K, Cronin A, Davis P, Goodhead I, 584 
Holroyd N, Jagels K, Lord A, Moule S, Mungall K, Norbertczak H, Quail MA, 585 
Rabbinowitsch E, Walker D, White B, Whitehead S, Small PLC, Brosch R, Ramakrishnan 586 
L, Fischbach MA, Parkhill J, Cole ST. 2008. Insights from the complete genome sequence 587 
of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 588 
18:729–741. 589 
8.  Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. 2000. Overview of 590 
membrane transport proteins, In Molecular cell biology, 4th ed, WH Freeman, New York. 591 
29 
 
9.  Cook GM, Berney M, Gebhard S, Heinemann M, Cox RA, Danilchanka O, Niederweis M. 592 
2009. Physiology of Mycobacteria. Adv Microb Physiol 55:81–182, 318–319. 593 
10.  Roberts LD, Souza AL, Gerszten RE, Clish CB. 2012. Targeted metabolomics. Curr Protoc 594 
Mol Biol Chapter 30:Unit 30.2-30.2.24. 595 
11.  Gouzy A, Larrouy-Maumus G, Wu T-D, Peixoto A, Levillain F, Lugo-Villarino G, 596 
Guerquin-Kern J-L, de Carvalho LPS, Poquet Y, Neyrolles O. 2013. Mycobacterium 597 
tuberculosis nitrogen assimilation and host colonization require aspartate. Nat Chem Biol 598 
9:674–676. 599 
12.  Gouzy A, Poquet Y, Neyrolles O. 2014. Nitrogen metabolism in Mycobacterium 600 
tuberculosis physiology and virulence. Nat Rev Microbiol 12:729–737. 601 
13.  Gouzy A, Larrouy-Maumus G, Bottai D, Levillain F, Dumas A, Wallach JB, Caire-Brandli 602 
I, de Chastellier C, Wu T-D, Poincloux R, Brosch R, Guerquin-Kern J-L, Schnappinger D, 603 
Sório de Carvalho LP, Poquet Y, Neyrolles O. 2014. Mycobacterium tuberculosis Exploits 604 
Asparagine to Assimilate Nitrogen and Resist Acid Stress during Infection. PLoS Pathog 605 
10:e1003928. 606 
14.  Smeulders MJ, Keer J, Speight RA, Williams HD. 1999. Adaptation of Mycobacterium 607 
smegmatis to stationary phase. J Bacteriol 181:270-283. 608 
15.  Jack DL, Paulsen IT, Saier MH. 2000. The amino acid/polyamine/organocation (APC) 609 
superfamily of transporters specific for amino acids, polyamines and organocations. 610 
Microbiology 146:1797–1814. 611 
16.  Consortium TU, The UniProt Consortium. 2019. UniProt: a worldwide hub of protein 612 
knowledge. Nucleic Acids Res 47:D506-D515. 613 
30 
 
17.  Krogh A, Larsson B, von Heijne G, Sonnhammer EL. 2001. Predicting Transmembrane 614 
Protein Topology with a Hidden Markov Model: Application to Complete Genomes. J Mol 615 
Biol 305:567–580. 616 
18.  Edwards N, Anderson CHM, Conlon NJ, Watson AK, Hall RJ, Cheek TR, Embley TM, 617 
Thwaites DT. 2018. Resculpting the binding pocket of APC superfamily LeuT-fold amino 618 
acid transporters. Cell Mol Life Sci 75:921-938. 619 
19.  Owens DF, Kriegstein AR. 2002. Is there more to GABA than synaptic inhibition? Nat Rev 620 
Neurosci 3:715–727. 621 
20.  Kim JK, Kim YS, Lee H-M, Jin HS, Neupane C, Kim S, Lee S-H, Min J-J, Sasai M, Jeong 622 
J-H, Choe S-K, Kim J-M, Yamamoto M, Choy HE, Park JB, Jo E-K. 2018. GABAergic 623 
signaling linked to autophagy enhances host protection against intracellular bacterial 624 
infections. Nat Commun 9:4184. 625 
21.  Dagorn A, Hillion M, Chapalain A, Lesouhaitier O, Duclairoir Poc C, Vieillard J, Chevalier 626 
S, Taupin L, Le Derf F, Feuilloley MGJ. 2013. Gamma-aminobutyric acid acts as a specific 627 
virulence regulator in Pseudomonas aeruginosa. Microbiology 159:339–351. 628 
22.  Ferson AE, Wray LV, Fisher SH. 1996. Expression of the Bacillus subtilis gabP gene is 629 
regulated independently in response to nitrogen and amino acid availability. Mol Microbiol 630 
22:693-701. 631 
31 
 
23.  McCraw SL, Park DH, Jones R, Bentley A, Rico A, Ratcliffe RG, Kruger NJ, Collmer A, 632 
Preston GM. 2016. GABA (γ-Aminobutyic Acid) Uptake Via the GABA Permease GabP 633 
Represses Virulence Gene Expression in Pseudomonas syringae pv. tomato DC3000. Mol. 634 
Plant Microbe Interact. 29:938-949. 635 
24.  Dover S, Halpern YS. 1972. Utilization of γ-Aminobutyric Acid as the Sole Carbon and 636 
Nitrogen Source by Escherichia coli K-12 Mutants. J Bacteriol 109:835-843. 637 
25.  Ma Z, Gong S, Richard H, Tucker DL, Conway T, Foster JW. 2003. GadE (YhiE) activates 638 
glutamate decarboxylase-dependent acid resistance in Escherichia coli K-12. Mol 639 
Microbiol 49:1309-1320. 640 
26.  Gong L, Ren C, Xu Y. (2020) GlnR Negatively Regulates Glutamate-Dependent Acid 641 
Resistance in Lactobacillus brevis. Appl Environ Microbiol 86:e02615-19. 642 
27.  Seth A, Connel ND. 2000. Amino Acid Transport and Metabolism in Mycobacteria: 643 
Cloning, Interruption, and Characterization of an L-Arginine/ γ-Aminobutyric Acid 644 
Permease in Mycobacterium bovis BCG. J Bacteriol 182:919-927. 645 
28.  Alexandrov AI, Mileni M, Chien EYT, Hanson MA, Stevens RC. 2008. Microscale 646 
Fluorescent Thermal Stability Assay for Membrane Proteins. Structure 16:351-359. 647 
29.  Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM. 2009. Detergent binding explains 648 
anomalous SDS-PAGE migration of membrane proteins. Proc Natl Acad Sci U S A 649 
106:1760–1765. 650 
30.  Hayashi Y, Matsui H, Takagi T. 1989. Membrane Protein Molecular Weight Determined 651 
by Low-Angle Laser Light-Scattering Photometry Coupled with High-Performance Gel 652 
Chromatography, Methods Enzymol 172:514-528.  653 
32 
 
31.  Pressman BC, Fahim M. 1982. Pharmacology and toxicology of the monovalent carboxylic 654 
ionophores. Annu Rev Pharmacol Toxicol 22:465–490.33.   655 
32.  Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll 656 
EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS. 2004. Glide: a new approach 657 
for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J 658 
Med Chem 47:1739-1749. 659 
33.  Gao X, Zhou L, Jiao X, Lu F, Yan C, Zeng X, Wang J, Shi Y. 2010. Mechanism of substrate 660 
recognition and transport by an amino acid antiporter. Nature 463:828-832. 661 
34.  Warner DF. 2014. Mycobacterium tuberculosis Metabolism. Cold Spring Harb Perspect 662 
Med 5:a021121. 663 
35.  Zaprasis A, Hoffmann T, Stannek L, Gunka K, Commichau FM, Bremer E. 2014. The γ-664 
aminobutyrate permease GabP serves as the third proline transporter of Bacillus subtilis. J 665 
Bacteriol 196:515–526. 666 
36. Kahane S, Levitz R, Halpern YS. 1978. Specificity and Regulation of γ-Aminobutyrate 667 
Transport in Escherichia coli. J Bacteriol. 135:295-299.  668 
37. Atkinson MR, Fisher SH. 1991. Identification of Genes and Gene Products Whose 669 
Expression is Activated during Nitrogen-Limited Growth in Bacillus subtilis. J Bacteriol 670 
173:23-27. 671 
38.  Bartsch K, von Johnn-Marteville A, Schulz A. 1990. Molecular Analysis of Two Genes of 672 
the Escherichia coli gab Cluster: Nucleotide Sequence of the Glutamate:Succinic 673 
Semialdehyde Transaminase Gene (gabT) and Characterization of the Succinic 674 
Semialdehyde Dehydrogenase Gene (gabD). J Bacteriol 172:7035–7042. 675 
33 
 
39.  Saidijam M, Bettaney KE, Szakonyi G, Psakis G, Shibayama K, Suzuki S, Clough JL, 676 
Blessie V, Abu-Bakr A, Baumberg S, Meuller J, Hoyle CK, Palmer SL, Butaye P, 677 
Walravens K, Patching SG, O’reilly J, Rutherford NG, Bill RM, Roper DI, Phillips-Jones 678 
MK, Henderson PJF. 2005. Active membrane transport and receptor proteins from bacteria. 679 
Biochem Soc Trans 33:867–872. 680 
40.  Zhao Z, Ding J-Y, Ma W-H, Zhou N-Y, Liu S-J. 2012. Identification and Characterization 681 
of γ-Aminobutyric Acid Uptake System GabPCg (NCgl0464) in Corynebacterium 682 
glutamicum. Appl Environ Microbiol 78:2596-2601. 683 
41.  Iversen LL, Kelly JS. 1975. Uptake and metabolism of γ-aminobutyric acid by neurones and 684 
glial cells. Biochem Pharmacol 24:933-938. 685 
42.  Brechtel CE, King SC. 1998. 4-Aminobutyrate (GABA) transporters from the amine-686 
polyamine-choline superfamily: substrate specificity and ligand recognition profile of the 687 
4-aminobutyrate permease from Bacillus subtilis. Biochem J 333:565–571. 688 
43.  Kellosalo J, Kajander T, Honkanen R, Goldman A. 2013. Crystallization and preliminary 689 
X-ray analysis of membrane-bound pyrophosphatases. Mol Membr Biol 30:64-74. 690 
44.  Screpanti E, Padan E, Rimon A, Michel H, Hunte C. 2006. Crucial Steps in the Structure 691 
Determination of the Na+/H+ Antiporter NhaA in its Native Conformation. J Mol Biol 692 
36:192-202. 693 
45.  Moss FJ, Imoukhuede PI, Scott K, Hu J, Jankowsky JL, Quick MW, Lester HA. 2009. 694 
GABA transporter function, oligomerization state, and anchoring: correlates with 695 
subcellularly resolved FRET. J Gen Physiol 134:489–521. 696 
34 
 
46.  Li X-D, Villa A, Gownley C, Kim MJ, Song J, Auer M, Wang D-N. 2001. Monomeric state 697 
and ligand binding of recombinant GABA transporter from Escherichia coli. FEBS Lett 698 
494:165-169. 699 
47.  Rehan S, Jaakola V-P. 2015. Expression, purification and functional characterization of 700 
human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells. 701 
Protein Expr Purif 114:99-107. 702 
48.  Corin K, Baaske P, Geissler S, Wienken CJ, Duhr S, Braun D, Zhang S. 2011. Structure and 703 
function analyses of the purified GPCR human vomeronasal type 1 receptor 1. Sci Rep 704 
1:172. 705 
49.  Parmar MM, Edwards K, Madden TD. 1999. Incorporation of bacterial membrane proteins 706 
into liposomes: factors influencing protein reconstitution. Biochim Biophys Acta 1421:77–707 
90. 708 
50.  Pramod AB, Foster J, Carvelli L, Henry LK. 2013. SLC6 transporters: structure, function, 709 
regulation, disease association and therapeutics. Mol Aspects Med 34:197–219. 710 
51.  Bae JH, Miller, KJ. 1992. Identification of Two Proline Transport Systems in 711 
Staphylococcus aureus and Their Possible Roles in Osmoregulation. Appl Environ 712 
Microbiol 58:471-475 713 
35 
 
52.  Stark MJR. 1987. Multicopy expression vectors carrying the lac represser gene for regulated 714 
high-level expression of genes in Escherichia coli. Gene 51:255–267. 715 
53.  Ma C, Hao Z, Huysmans G, Lesiuk A, Bullough P, Wang Y, Bartlam M, Phillips SE, Young 716 
JD, Goldman A, Baldwin SA, Postis VLG. 2015. A Versatile Strategy for Production of 717 
Membrane Proteins with Diverse Topologies: Application to Investigation of Bacterial 718 
Homologues of Human Divalent Metal Ion and Nucleoside Transporters. PLoS One 719 
10:e0143010. 720 
54.  Postis VGL, Rawlings AE, Lesiuk A, Baldwin SA. 2013. Use of Escherichia coli for the 721 
production and purification of membrane proteins. Methods Mol Biol 998:33–54. 722 
55.  Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto 723 
EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of Protein using Bicinchoninic 724 
Acid. Anal Biochem 150:76-85. 725 
56.  Slotboom DJ, Duurkens RH, Olieman K, Erkens GB. 2008. Static light scattering to 726 
characterize membrane proteins in detergent solution. Methods 46:73–82. 727 
57.  Agapova A, Serafini A, Petridis M, Hunt DM, Garza-Garcia A, Sohaskey CD, Luiz Pedro 728 
Sório de Carvalho LP. 2019. Flexible nitrogen utilisation by the metabolic generalist 729 
pathogen Mycobacterium tuberculosis. eLife 8:e41129. 730 
58.  Seigneuret M, Rigaud J-L. 1985. Use of the fluorescent pH probe pyranine to detect 731 
heterogeneous directions of proton movement in bacteriorhodopsin reconstituted large 732 
liposomes. FEBS Lett 188:101–106. 733 
36 
 
59.  Huerta-Cepas J, Szklarczyk D, Heller D, Hernández-Plaza A, Forslund SK, Cook H, Mende 734 
DR, Letunic I, Rattei T, Jensen LJ, von Mering C, Bork P. 2019. eggNOG 5.0: a hierarchical, 735 
functionally and phylogenetically annotated orthology resource based on 5090 organisms 736 
and 2502 viruses. Nucleic Acids Res 47:309-314. 737 
60.  Li W, Godzik A. 2006. Cd-hit: a fast program for clustering and comparing large sets of 738 
protein or nucleotide sequences. Bioinformatics 22:1658-1659. 739 
61.  Katoh K, Misawa K, Kuma K, Miyata T. 2002. MAFFT: a novel method for rapid multiple 740 
sequence alignment based on fast Fourier transform. Nucleic Acids Res 30:3059-3066. 741 
62.  Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. 2009. Jalview Version 2--742 
a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189-743 
1191.  744 
63.  Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. 745 
BLAST+: architecture and applications. BMC Bioinformatics 10:421. 746 
64.  Edgar RC. (2004) MUSCLE: multiple sequence alignment with high accuracy and high 747 
throughput. Nucleic Acids Res 32:1792-1797. 748 
65.  Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. 2017. 749 
ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods 750 
14:587-589.  751 
66.  Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. 2015. IQ-TREE: a fast and effective 752 
stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol 753 
32:268-274.  754 
37 
 
67.  Huson DH, Scornavacca C. 2012. Dendroscope 3: an interactive tool for rooted phylogenetic 755 
trees and networks. Syst Biol 61:1061-7.  756 
68.  Kim DE, Chivian D, Baker D. 2004. Protein structure prediction and analysis using the 757 
Robetta server. Nucleic Acids Res 32:526-531. 758 
69.  Kelley L, Mezulis S, Yates CM, Wass MN, Sternberg MJE. 2015. The Phyre2 web portal 759 
for protein modelling, prediction and analysis. Nat Protoc 10:845-858. 760 
 761 
FIGURES 1 
 2 
FIG 1 Expression of MsGabP. The expression of MsGabP in E. coli was analysed by western 3 
blotting (band migrating at ~36 kDa indicated by an arrow, detected by anti-HIS antibody). Lanes 4 
represent MsGabP expression results in: (1) C41 (DE3) ΔacrB pRARE2; (2) C43 (DE3) ΔacrB 5 
pRARE2 (3) C41 (DE3) ΔacrB; (4) BL21 Star (DE3) pRARE2; (5) BL21 Gold (DE3) pRARE2. 6 
Media type labelled as follows: C: LB media containing glucose; L: LB auto-induction media; S: 7 
SB auto-induction media; M9: M9 auto-induction media. The gels were spliced for labelling 8 
purposes.   9 
  10 
 11 
FIG 2 Targeted metabolomics study results of GABA (A) and serine (B). The amino acids were 12 
tested with two concentrations, 1 mM and 5 mM. The black and grey bar represents uptake resulted 13 
from cells harbouring plasmid with MsGabP or the empty vector as control, respectively. The 14 
charts show means (bars) and standard deviations (error bars) of three biological replicates of one 15 
independent experiment. They are representative of two independent experiments. They y-axes 16 
report the ion counts normalised on residual protein content (ions counts/peptides*1000).  17 
  18 
 19 
FIG 3 Direct measurement of [3H]GABA uptake into E. coli cells. GABA: transport assay 20 
conducted in the presence of [3H]GABA; β-ala: unlabelled 5 mM β-alanine was added before the 21 
addition of [3H]GABA; CCCP: 50 μM CCCP was added before the addition of [3H]GABA. The 22 
black and grey bar respectively represents the GABA uptake from cells harbouring plasmid with 23 
the GabP gene or empty vector. The data are means of three measurements. Error bars indicate 24 
standard deviations.  25 
  26 
 27 
FIG 4 Solubilisation of MsGabP. A) Detergent solubilisation screen. Anti-His Western blot of the 28 
supernatant fractions following solubilisation with: (1) CYMAL 6; (2) LMNPG; (3) DMNPG; (4) 29 
OGNPG; (5) β-OG; (6) 14M; (7) 13M; (8) DDTM; (9) DDM; (10) UDTM; (11) UDM; (12) DM; 30 
Lane 13 is a membrane fraction with no detergent added; M represent protein molecular marker 31 
(kDa). B) Microscale fluorescent thermal stability assay of MsGabP. GabP purified with DDM at 32 
pH 7.0. The blue line represents data points collected during the MsGabP unfolding process and 33 
the black line from buffer blank control samples. Table shows the summary of Tm values calculated 34 
from the melting curves. Values shown are means of two separate measurements. 35 
  36 
 37 
FIG 5 SEC-MALLS analysis of purified MsGabP. A) SDS-PAGE of MsGabP eluted in DMNPG. 38 
The arrows indicate the bands on the gel corresponding to MsGabP at ~36 kDa and ~70 kDa. 39 
B) SEC-MALLS UV chromatogram. The thick orange, grey and blue lines indicate the molar mass 40 
distribution of the eluting protein, detergent and total complex respectively (scale on the right-41 
hand axis). Black lines indicate the part used for calculations of molar masses. 42 
  43 
 44 
FIG 6 Transport activity of the purified MsGabP reconstituted into liposomes. Radioactive GABA 45 
uptake measured in the presence of 200 mM NaCl (A) and 200 mM NaCl or 200 mM choline 46 
chloride, in the presence and absence of valinomycin (5 nM) and/or CCCP (0.03 mM) (B). GABA 47 
transport was measured for 10 min. C) Monitoring of pH variation during GABA transport with 48 
pyranine. The ratio of fluorescence at 450:400 nm is shown over time. The black and grey bars 49 
represent uptake resulted from proteoliposomes containing MsGabP and protein-free liposome as 50 
control samples, respectively. All liposomes were loaded with 25 mM HEPES (pH 6.8), including 51 
200 mM KCl. The data are means of three measurements. Error bars indicate standard deviations. 52 
 53 
TABLES  1 
Table 1. Detergents tested for solubilization efficiency and MsGabP yield after detergent  2 
exchange.  3 
Detergent Concentration 
 (x CMC) 
Concentration 
 (%) 
MsGabP yield after 
detergent exchange 
(%) 
DDM 5.7 0.05 100 
CYMAL 6 3 0.084 92.3 
-OG 3 1.59 0 
OGNPG 3 0.174 35.9 
DMNPG 3 0.0102 83.7 
LMNPG 3 0.003 0 
DM 3 0.261 71.8 
UDM 5 0.145 84.8 
UDTM 5 0.055 90.9 
DDTM 5 0.013 51.5 
13M 5 0.0085 72.7 
14M 5 0.0027 0 
n-Dodecyl-β-D-Maltopyranoside (DDM), 6-Cyclohexyl-1-hexyl-β-D-maltoside (CYMAL 6), n- 4 
Octyl-β-D-Glucopyranoside (β-OG), Octyl Glucose Neopentyl Glycol (OGNPG), Decyl Maltose 5 
Neopentyl Glycol (DMNPG), Lauryl Maltose Neopentyl Glycol (LMNPG), n-Decyl-β-D-6 
Maltopyranoside (DM), n-Undecyl-β-D-Maltopyranoside (UDM), n-Undecyl-β-D-  7 
Thiomaltopyranoside (UDTM), n-Dodecyl-β-D-Thiomaltopyranoside (DDTM), n-Tridecyl-β-D- 8 
Maltopyranoside (13M) and n-Tetradecyl-β-D-Maltopyranoside (14M). Values in the column 9 
“MsGabP yield after detergent exchange (%)” shows protein yield after detergent exchange. 10 
The  number was calculated using the amount of MsGabP obtained with eleven different detergents 11 
divided by the amount obtained from purification with DDM. CMC, critical micellar 12 
concentration.  13 
 14 
